Structures by: Xu H. D.
Total: 7
C23H28N2O4S
C23H28N2O4S
Organic letters (2015) 17, 1 66-69
a=10.543(2)Å b=9.344(2)Å c=22.465(5)Å
α=90.00° β=92.128(3)° γ=90.00°
N-(9a-allyl-6,8-dimethoxy-2,3,9,9a-tetrahydro-1H-pyrrolo[1,2-a]indol-9-yl)-4-methylbenzenesulfonamide
C23H28N2O4S
Organic letters (2015) 17, 1 66-69
a=26.688(6)Å b=18.145(5)Å c=9.062(2)Å
α=90.00° β=90.00° γ=90.00°
C29H35BN2O6
C29H35BN2O6
Organic & biomolecular chemistry (2019) 17, 6 1542-1546
a=16.0337(16)Å b=12.9982(13)Å c=14.0060(14)Å
α=90° β=99.941(3)° γ=90°
C12H14N2O3S
C12H14N2O3S
Organic & biomolecular chemistry (2016) 14, 4 1272-1276
a=8.3507(13)Å b=8.6494(14)Å c=9.0014(15)Å
α=79.307(3)° β=84.564(3)° γ=79.146(3)°
Ta4O(Te2)4TeI4
Ta4O(Te2)4TeI4
Acta Crystallographica Section C (1998) 54, 7 893-895
a=21.97(4)Å b=6.155(3)Å c=19.98(4)Å
α=90.° β=122.08(9)° γ=90.°
(TaTe4)6I4(TaI6)
(TaTe4)6I4(TaI6)
Acta Crystallographica Section C (1998) 54, 7 895-897
a=7.712(2)Å b=26.454(8)Å c=6.777(2)Å
α=91.06(2)° β=102.02(2)° γ=94.69(2)°
3-Diazo-<i>N</i>-[(2<i>S</i>)-1-hydroxypropan-2-yl]-2-oxopropanamide
C6H9N3O3
Acta Crystallographica Section E (2011) 67, 5 o1192
a=5.3136(3)Å b=6.7551(3)Å c=23.3958(11)Å
α=90.00° β=90.00° γ=90.00°